{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:46:29Z","timestamp":1780098389260,"version":"3.54.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1053\/j.ackd.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T20:32:51Z","timestamp":1575923571000},"page":"409-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Mineral Bone Abnormalities and Vascular Calcifications"],"prefix":"10.1053","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1344-3332","authenticated-orcid":false,"given":"Matthew","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Jovanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib1","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1053\/j.ajkd.2004.07.022","article-title":"Coronary artery calcification in patients with CRF not undergoing dialysis","volume":"44","author":"Russo","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","article-title":"Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients","volume":"27","author":"Braun","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2215\/CJN.07450714","article-title":"Vascular calcification in patients with nondialysis CKD over 3 years","volume":"10","author":"Gorriz","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2215\/CJN.06240909","article-title":"Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up","volume":"5","author":"Watanabe","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamacardio.2017.0363","article-title":"Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease","volume":"2","author":"Chen","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1542-4758.2012.00739.x","article-title":"Association of coronary artery calcium score and vascular dysfunction in long-term hemodialysis patients","volume":"17","author":"Zeb","year":"2013","journal-title":"Hemodial Int"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000294405","article-title":"Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients","volume":"31","author":"Shantouf","year":"2010","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib8","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1172\/JCI116391","article-title":"Bone morphogenetic protein expression in human atherosclerotic lesions","volume":"91","author":"Bostrom","year":"1993","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1681\/ASN.2011121191","article-title":"Mechanistic insights into vascular calcification in CKD","volume":"24","author":"Schroff","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"37","key":"10.1053\/j.ackd.2019.09.004_bib10","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.2174\/1381612820666140212194926","article-title":"Vascular calcification in chronic kidney disease: role of disordered mineral metabolism","volume":"20","author":"Palit","year":"2014","journal-title":"Curr Pharm Des"},{"issue":"113","key":"10.1053\/j.ackd.2019.09.004_bib11","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.004_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorous, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systemic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib13","first-page":"281","article-title":"Association of serum phosphate with vascular and valvular calcification in moderate CKD","volume":"20","author":"Adeny","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jim-2018-000852","article-title":"Fractional excretion of phosphorous and vascular calcification in stage 3 chronic kidney disease","volume":"67","author":"Jimenez Villodres","year":"2019","journal-title":"J Investig Med"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib15","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/j.ajkd.2011.07.020","article-title":"The role of phosphorus in the development and progression of vascular calcification","volume":"58","author":"Kendrick","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.004_bib16","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/01.ATV.0000059406.92165.31","article-title":"Osteo\/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification","volume":"23","author":"Tyson","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.004_bib18","first-page":"2077","article-title":"Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia","volume":"76","author":"Voelkl","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.004_bib19","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib20","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.ajpath.2010.10.006","article-title":"Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in uremic mouse model of chronic kidney disease","volume":"178","author":"Pai","year":"2011","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.004_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.87.11.1055","article-title":"Apoptosis regulates human vascular calcification in\u00a0vitro: evidence for initiation of vascular calcification by apoptotic bodies","volume":"87","author":"Proudfoot","year":"2000","journal-title":"Circ Res"},{"issue":"8","key":"10.1053\/j.ackd.2019.09.004_bib23","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.RES.0000218859.90970.8d","article-title":"Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway","volume":"98","author":"Son","year":"2006","journal-title":"Circ Res"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1096\/fj.01-0898hyp","article-title":"Rationale for the role of osteoclast-like cells in arterial calcifications","volume":"16","author":"Doherty","year":"2002","journal-title":"FASEB J"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jcp.21283","article-title":"High extracellular inorganic phosphate concentration inhibits RANK-RANKL signaling in osteoclast-like cells","volume":"215","author":"Mozar","year":"2008","journal-title":"J Cell Physiol"},{"issue":"9","key":"10.1053\/j.ackd.2019.09.004_bib26","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ki.2008.644","article-title":"The emerging role of phosphate in vascular calcification","volume":"75","author":"Giachelli","year":"2009","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jamainternmed.2019.0043","article-title":"Comparative safety of phosphate binders without proven efficacy\u2014how did we get here?","volume":"179","author":"Kestenbaum","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1681\/ASN.2018101058","article-title":"Effects of nicotinaminde and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: the COMBINE trial","volume":"30","author":"Ix","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2019.09.004_bib29","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1681\/ASN.2011121213","article-title":"Npt2b deletion attenuates hyperphosphatemia associated with CKD","volume":"23","author":"Schiavi","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"10.1053\/j.ackd.2019.09.004_bib30","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patient with different levels of serum calcium, phosphorus and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib32","first-page":"F945","article-title":"Extracellular calcium-sensing receptor is functionally expressed in human artery","volume":"293","author":"Molostvov","year":"2007","journal-title":"Am J Ren Physiol Ren Physiol"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib33","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cvr\/cvn279","article-title":"Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells","volume":"81","author":"Alum","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib34","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.110.238808","article-title":"Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization","volume":"109","author":"Kapustin","year":"2011","journal-title":"Circ Res"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib35","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.108.181305","article-title":"Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization","volume":"103","author":"Ewence","year":"2008","journal-title":"Circ Res"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib36","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorous balance in stage 3-4 kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.004_bib37","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MNH.0000000000000416","article-title":"Rationale to reduce calcium intake in patients with chronic kidney disease","volume":"27","author":"Moe","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"10.1053\/j.ackd.2019.09.004_bib39","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/ndt\/gfp078","article-title":"R-568 reduces ectopic calcification in a rat model of chronic kidney disease-mineral bone disorder (CKD-MBD)","volume":"24","author":"Moe","year":"2009","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib40","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorous and calcium x phosphorous product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"A J Kid Dis"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.ki.5002059","article-title":"Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients","volume":"71","author":"Block","year":"2007","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","article-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial","volume":"62","author":"Dilorio","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ackd.2019.09.004_bib45","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1001\/jamainternmed.2019.0045","article-title":"Cardiovascular outcomes of calcium-free vs calcium-based phosphate binders in patients 65 years or older with end-stage renal disease requiring hemodialysis","volume":"179","author":"Spoendlin","year":"2019","journal-title":"JAMA Int Med"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib48","doi-asserted-by":"crossref","first-page":"c109","DOI":"10.1159\/000108652","article-title":"Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The Chronic Renal Impairment in Birmingham (CRIB) study","volume":"107","author":"Zehnder","year":"2007","journal-title":"Nephron Clin Pract"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib49","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib50","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in\u00a0vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in\u00a0vitro","volume":"293","author":"Perwad","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.ajkd.2012.04.014","article-title":"Associations of plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentrations with death and progression to maintenance dialysis in patients with advanced kidney disease","volume":"60","author":"Kendrick","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcomes in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib53","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1681\/ASN.2014101009","article-title":"Low vitamin D and high fibroblast growth factor 23 serum levels associated with infectious cardiac deaths in the HEMO study","volume":"27","author":"Chonchol","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib54","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/ajcn\/87.6.1631","article-title":"Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-yr prospective cohort study","volume":"87","author":"Wang","year":"2008","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1053\/j.ackd.2019.09.004_bib55","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.ki.5002451","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"72","author":"Wolf","year":"2007","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib56","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ndt\/gfg513","article-title":"Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population","volume":"19","author":"Shoji","year":"2004","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib57","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib58","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ckj\/sfu122","article-title":"Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis","volume":"8","author":"Mann","year":"2015","journal-title":"Clin Kidney J"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib60","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ndt\/gfn502","article-title":"25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients","volume":"24","author":"Matias","year":"2009","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib61","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1681\/ASN.2007090993","article-title":"A bimodal association of vitamin D levels and vascular disease in children on dialysis","volume":"19","author":"Shroff","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2019.09.004_bib62","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10791016","article-title":"Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD","volume":"12","author":"Levin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ackd.2019.09.004_bib63","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2215\/CJN.01870217","article-title":"Cholecalciferol, calcitriol, and vascular function in CKD: a randomized, double-blind trial","volume":"12","author":"Kendrick","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.004_bib64","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/ajh\/hpu057","article-title":"Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observation study","volume":"27","author":"Fortier","year":"2014","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib65","doi-asserted-by":"crossref","first-page":"E652","DOI":"10.3390\/nu10050652","article-title":"Vitamin D in vascular calcification: a double-edged sword?","volume":"10","author":"Wang","year":"2018","journal-title":"Nutrients"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.004_bib66","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ki.2010.432","article-title":"The dualistic role of vitamin D in vascular calcifications","volume":"79","author":"Razzaque","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOL.0b013e328011c6fc","article-title":"Vitamin D and vascular calcification","volume":"18","author":"Zittermann","year":"2007","journal-title":"Curr Opin Lipidol"},{"issue":"8","key":"10.1053\/j.ackd.2019.09.004_bib68","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.ki.5000304","article-title":"1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediate pathway","volume":"69","author":"Cardus","year":"2006","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ackd.2019.09.004_bib69","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1359\/jbmr.2002.17.9.1604","article-title":"1Alpha,25-dihydroxyvitamin D3 promotes vascularization of the chondro-osseus junction by stimulating expression of vascular endothelial growth factor and matrix metalloproteinase 9","volume":"17","author":"Lin","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib70","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.070305","article-title":"Differential effects of vitamin D analogs on vascular calcification","volume":"22","author":"Cardus","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"13","key":"10.1053\/j.ackd.2019.09.004_bib71","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.98.13.1302","article-title":"1,25-Dihydroxyvitamin D3 increases in\u00a0vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide","volume":"98","author":"Jono","year":"1998","journal-title":"Circulation"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib72","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/ndt\/gfi273","article-title":"Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rates with adenine-induced uraemia","volume":"21","author":"Tamagaki","year":"2006","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib73","doi-asserted-by":"crossref","first-page":"e35316","DOI":"10.1371\/journal.pone.0035316","article-title":"Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice","volume":"7","author":"Schmidt","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib74","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3945\/jn.113.189118","article-title":"Dietary vitamin D inadequacy accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor knockout and wild-type mice","volume":"144","author":"Schmidt","year":"2014","journal-title":"J Nutr"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib75","doi-asserted-by":"crossref","first-page":"e88767","DOI":"10.1371\/journal.pone.0088767","article-title":"Vitamin D deficiency and exogenous vitamin D excess similarly increase diffuse atherosclerotic calcification in apolipoprotein E knockout mice","volume":"9","author":"Ellam","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib76","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/ndt\/gfr758","article-title":"Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF\u03b1","volume":"27","author":"Aoshima","year":"2012","journal-title":"Nephrol Dial Transpl"},{"key":"10.1053\/j.ackd.2019.09.004_bib77","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcme.2014.06.003","article-title":"Vitamin D and the endothelium: basic, translational and clinical research updates","volume":"4","author":"Dalan","year":"2014","journal-title":"IJC Metab Endocr"},{"issue":"S5","key":"10.1053\/j.ackd.2019.09.004_bib78","doi-asserted-by":"crossref","first-page":"v2","DOI":"10.1093\/ndt\/gfh1049","article-title":"The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes","volume":"19","author":"Horl","year":"2004","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib79","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.bjp.0704378","article-title":"Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets","volume":"134","author":"Clemens","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib80","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.ATV.17.6.1135","article-title":"Parathyroid hormone-related peptide as a local regulator of vascular calcification. Its inhibitory action on in\u00a0vitro calcification by bovine vascular smooth muscle cells","volume":"17","author":"Jono","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib81","first-page":"1754","article-title":"Parathyroid hormone promotes osteoblastic differentiation of endothelial cells via the extracellular signal-regulated protein kinase \u00bd and nuclear factor-\u03baB signaling pathways","volume":"15","author":"Cheng","year":"2018","journal-title":"Exp Ther Med"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib82","doi-asserted-by":"crossref","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","article-title":"Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways","volume":"292","author":"Rashid","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib83","doi-asserted-by":"crossref","first-page":"F60","DOI":"10.1152\/ajprenal.00622.2007","article-title":"Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C","volume":"296","author":"Rashid","year":"2009","journal-title":"Am J Physiol Ren Physiol"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib84","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ndt\/gfy287","article-title":"High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease","volume":"34","author":"Lopez-Carrillo","year":"2019","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"10.1053\/j.ackd.2019.09.004_bib85","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/sj.ki.5002241","article-title":"Vascular calcification: contribution of parathyroid hormone in renal failure","volume":"71","author":"Neves","year":"2007","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.004_bib86","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1097\/HJH.0b013e328357c049","article-title":"Submaximal suppression of parathyroid hormone ameliorates calcitriol-induced aortic calcification and remodeling and myocardial fibrosis in uremic rats","volume":"30","author":"Jung","year":"2012","journal-title":"J Hypertens"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib87","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2215\/CJN.12941213","article-title":"Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study","volume":"10","author":"Tentori","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"21","key":"10.1053\/j.ackd.2019.09.004_bib88","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","article-title":"Plasma parathyroid hormone and the risk of cardiovascular mortality in the community","volume":"119","author":"Hagstrom","year":"2009","journal-title":"Circulation"},{"issue":"11","key":"10.1053\/j.ackd.2019.09.004_bib89","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1093\/ndt\/gfm370","article-title":"Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?","volume":"22","author":"Coen","year":"2007","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib90","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: from bone to vessels in chronic kidney disease","volume":"34","author":"Bover","year":"2014","journal-title":"Semin Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib91","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ajkd.2005.04.035","article-title":"Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD","volume":"46","author":"Bleyer","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib92","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patient on hemodialysis","volume":"26","author":"Raggi","year":"2011","journal-title":"Nephrol Dial Transpl"},{"issue":"2","key":"10.1053\/j.ackd.2019.09.004_bib93","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5414\/CN106757","article-title":"Serum fetuin-A levels increased following parathyroidectomy in uremic hyperparathyroidism","volume":"77","author":"Wang","year":"2012","journal-title":"Clin Nephrol"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.004_bib94","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of alpha1(1) collagen promoter exhibit growth retardation, osteomalacia, an disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib95","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib96","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.004_bib97","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1681\/ASN.2009040427","article-title":"FGF23 fails to inhibit uremic parathyroid glands","volume":"12","author":"Canalejo","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib98","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ndt\/gfp699","article-title":"Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study","volume":"25","author":"Ix","year":"2010","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"10.1053\/j.ackd.2019.09.004_bib99","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"issue":"23","key":"10.1053\/j.ackd.2019.09.004_bib100","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patient with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1053\/j.ackd.2019.09.004_bib101","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib102","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.004_bib103","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","article-title":"FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages","volume":"23","author":"Desjarins","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1053\/j.ackd.2019.09.004_bib104","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2016.08.010","article-title":"Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells","volume":"253","author":"Nakahara","year":"2016","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib105","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ki.2013.3","article-title":"Fibroblast growth factor 23 is not associated with and does not induce arterial calcification","volume":"83","author":"Scialla","year":"2013","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib106","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2559.2010.03547.x","article-title":"Fibroblast growth factor (FGF)-23 and fetuin-A in calcified carotid atheroma","volume":"56","author":"Voigt","year":"2010","journal-title":"Histopathology"},{"issue":"8","key":"10.1053\/j.ackd.2019.09.004_bib107","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/ndt\/gft523","article-title":"FGF23 protein expression in coronary arteries is associated with impaired kidney function","volume":"29","author":"van Venrooij","year":"2014","journal-title":"Nephrol Dial Transpl"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib108","doi-asserted-by":"crossref","first-page":"e60658","DOI":"10.1371\/journal.pone.0060658","article-title":"Arterial klotho expression and FGF23 effects on vascular calcification and function","volume":"8","author":"Lindberg","year":"2013","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1053\/j.ackd.2019.09.004_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2013.03.008","article-title":"A protective role for FGF23 in local defense against disrupted arterial wall integrity?","volume":"372","author":"Zhu","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"10.1053\/j.ackd.2019.09.004_bib110","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1053\/j.ackd.2019.09.004_bib111","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","article-title":"Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of klotho deficiency","volume":"85","author":"Jimbo","year":"2014","journal-title":"Kidney Int"},{"issue":"18","key":"10.1053\/j.ackd.2019.09.004_bib112","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib113","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib114","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ki.2015.160","article-title":"Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via klotho upregulation","volume":"88","author":"Zhao","year":"2015","journal-title":"Kidney Int"},{"issue":"5-6","key":"10.1053\/j.ackd.2019.09.004_bib115","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/08977194.2015.1108313","article-title":"Secreted klotho protein attenuates osteogenic differentiation of human bone marrow mesenchymal stem cells in\u00a0vitro via inactivation of the FGFR1\/ERK signaling pathway","volume":"33","author":"Zhang","year":"2015","journal-title":"Growth Factors"},{"issue":"3","key":"10.1053\/j.ackd.2019.09.004_bib116","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.kint.2015.12.029","article-title":"Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of \u03b1-klotho","volume":"89","author":"Chang","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib117","doi-asserted-by":"crossref","first-page":"e93423","DOI":"10.1371\/journal.pone.0093423","article-title":"Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium","volume":"9","author":"Six","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib118","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.kint.2017.06.019","article-title":"Identifying early pathogenic events during vascular calcification in uremic rats","volume":"92","author":"Hortells","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2019.09.004_bib119","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ackd.2019.09.004_bib120","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","article-title":"Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in\u00a0vitro","volume":"23","author":"Wang","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"26","key":"10.1053\/j.ackd.2019.09.004_bib121","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patient undergoing dialysis","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2019.09.004_bib122","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.semnephrol.2018.05.009","article-title":"Personalized management of bone and mineral disorders and precision medicine in end-stage kidney disease","volume":"38","author":"Jovanovich","year":"2018","journal-title":"Semin Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559519301685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:01:47Z","timestamp":1761548507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559519301685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":121,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1548559519301685"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2019.09.004","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineral Bone Abnormalities and Vascular Calcifications","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}